FIBROCOR THERAPEUTICS
Fibrocor Therapeutics is focused on developing disease modifying therapeutics in fibrosis.The company has already identified a lead program and will partner with Evotec to develop novel molecules .
FIBROCOR THERAPEUTICS
Industry:
Biopharma Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2017-01-01
Address:
Toronto, Ontario, Canada
Country:
Canada
Website Url:
http://www.fibrocortherapeutics.com
Total Employee:
11+
Status:
Active
Total Funding:
2.8 M CAD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Mobile Non Scaleable Content Nginx Euro
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Bicara Therapeutics
Bicara Therapeutics is developing a pipeline of bifunctional antibodies that exploit the recent advances in immuno-oncology.
D2M Biotherapeutics
D2M Biotherapeutics focuses on the development of novel immunotherapeutics.
Disarm Therapeutics
Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.
Modis Therapeutics
Modis Therapeutics is bringing disease-modifying therapies to patients with rare genetic diseases.
Current Employees Featured
Founder
Investors List
Toronto Innovation Acceleration Partners
Toronto Innovation Acceleration Partners investment in Seed Round - Fibrocor Therapeutics
Official Site Inspections
http://www.fibrocortherapeutics.com Semrush global rank: 5.24 M Semrush visits lastest month: 1.56 K
- Host name: a4ec4c6ea1c92e2e6.awsglobalaccelerator.com
- IP address: 15.197.142.173
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
